Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  October 15, 2021 in 340B Health News Releases

• How drugmaker restrictions on 340B discounts affect hospital pharmacies: 5 systems weigh in

  October 04, 2021 in 340B in the News

• STATEMENT ON FEDERAL 340B ENFORCEMENT ACTIONS AGAINST BOEHRINGER INGELHEIM

  October 04, 2021 in 340B Health News Releases

• SIX DRUG COMPANIES REFERRED FOR PENALTIES FOR CONTINUED VIOLATIONS OF FEDERAL LAW ON 340B PRICING

  September 22, 2021 in 340B Health News Releases

• DIABETES DRUGS HEAVILY IMPACTED BY DRUGMAKERS’ 340B POLICIES

  September 15, 2021 in 340B Health News Releases

• STATEMENT ON MERCK CUTTING OFF 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  August 13, 2021 in 340B Health News Releases

• STATEMENT ON HOUSE LANGUAGE IN SUPPORT OF ENDING DRUG COMPANY ATTACKS ON 340B

  July 28, 2021 in 340B Health News Releases

• STATEMENT ON PROPOSED MEDICARE PAYMENT CUTS TO 340B HOSPITALS IN 2022

  July 19, 2021 in 340B Health News Releases

• STATEMENT ON THE BIPARTISAN PROTECT 340B ACT TO STOP DISCRIMINATORY ACTIONS BY PBMS AND INSURERS

  July 09, 2021 in 340B Health News Releases

• 340B HEALTH CALLS ON BOEHRINGER INGELHEIM TO WITHDRAW THREAT TO DENY DRUG DISCOUNTS TO SAFETY-NET HOSPITALS

  July 07, 2021 in 340B Health News Releases

• STATEMENT ON U.S. SUPREME COURT ORDER IN 340B MEDICARE CUTS LAWSUIT

  July 02, 2021 in 340B Health News Releases

• STATEMENT ON WITHDRAWAL OF HHS ADVISORY OPINION ON 340B COMMUNITY PHARMACIES

  June 21, 2021 in 340B Health News Releases